JP2006008637A5 - - Google Patents

Download PDF

Info

Publication number
JP2006008637A5
JP2006008637A5 JP2004191446A JP2004191446A JP2006008637A5 JP 2006008637 A5 JP2006008637 A5 JP 2006008637A5 JP 2004191446 A JP2004191446 A JP 2004191446A JP 2004191446 A JP2004191446 A JP 2004191446A JP 2006008637 A5 JP2006008637 A5 JP 2006008637A5
Authority
JP
Japan
Prior art keywords
anion exchange
pharmaceutical composition
exchange resin
feeling
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004191446A
Other languages
English (en)
Other versions
JP4845353B2 (ja
JP2006008637A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004191446A priority Critical patent/JP4845353B2/ja
Priority claimed from JP2004191446A external-priority patent/JP4845353B2/ja
Publication of JP2006008637A publication Critical patent/JP2006008637A/ja
Publication of JP2006008637A5 publication Critical patent/JP2006008637A5/ja
Application granted granted Critical
Publication of JP4845353B2 publication Critical patent/JP4845353B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (9)

  1. 陰イオン交換樹脂を含む医薬組成物であって、陰イオン交換樹脂の吸水膨潤抑制剤を含み、服用感が改善された医薬組成物。
  2. 服用感の改善が、陰イオン交換樹脂の口腔内でのざらつき感の軽減及び/又は口腔内粘膜への付着の抑制である請求項1に記載の医薬組成物
  3. 吸水膨潤抑制剤が増粘剤ないしゲル化剤、塩類、及び糖類からなる群から選ばれる1種以上の物質を含む請求項1又は2に記載の医薬組成物。
  4. 陰イオン交換樹脂の吸水膨潤後の粒径が200μm以下となるように吸水膨潤が抑制された請求項1ないし3のいずれか1項に記載の医薬組成物。
  5. 陰イオン交換樹脂が、コレスチミド、コレスチラミン、コレスチポール、塩酸セベレマー、又は塩酸コレセベラムである請求項1ないし4のいずれか1項に記載の医薬組成物。
  6. 用時懸濁型の製剤である請求項1ないし5のいずれか1項に記載の医薬組成物。
  7. 陰イオン交換樹脂の吸水膨潤抑制剤であって、増粘剤ないしゲル化剤、塩類、及び糖類からなる群から選ばれる1種以上の物質を含む吸水膨潤抑制剤。
  8. 陰イオン交換樹脂を含む医薬組成物の服用感を改善するために用いる請求項7に記載吸水膨潤抑制剤。
  9. 服用感の改善が陰イオン交換樹脂の口腔内でのざらつき感の軽減及び/又は口腔内粘膜への付着の抑制である請求項に記載の吸水膨潤抑制剤。
JP2004191446A 2004-06-29 2004-06-29 陰イオン交換樹脂を含む医薬組成物 Expired - Fee Related JP4845353B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004191446A JP4845353B2 (ja) 2004-06-29 2004-06-29 陰イオン交換樹脂を含む医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004191446A JP4845353B2 (ja) 2004-06-29 2004-06-29 陰イオン交換樹脂を含む医薬組成物

Publications (3)

Publication Number Publication Date
JP2006008637A JP2006008637A (ja) 2006-01-12
JP2006008637A5 true JP2006008637A5 (ja) 2007-08-30
JP4845353B2 JP4845353B2 (ja) 2011-12-28

Family

ID=35776270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004191446A Expired - Fee Related JP4845353B2 (ja) 2004-06-29 2004-06-29 陰イオン交換樹脂を含む医薬組成物

Country Status (1)

Country Link
JP (1) JP4845353B2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CN101272762B (zh) 2005-09-15 2013-02-06 基酶有限公司 胺聚合物的小袋制剂
JPWO2007094413A1 (ja) * 2006-02-16 2009-07-09 学校法人 東洋大学 経皮投与用医薬組成物
TWI605837B (zh) * 2011-01-27 2017-11-21 Kowa Co Ltd Pharmaceutical composition containing water-insoluble drug and pharmaceutical preparation
CN105476969A (zh) * 2015-12-18 2016-04-13 北京万全德众医药生物技术有限公司 考来替兰分散片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01172324A (ja) * 1987-12-15 1989-07-07 Armour Internatl Co コレスチラミン組成物及びその製造法
JPH02124819A (ja) * 1988-11-01 1990-05-14 Mitsubishi Kasei Corp 経口コレステロール低下剤
JP2000516263A (ja) * 1997-12-29 2000-12-05 ザ、プロクター、エンド、ギャンブル、カンパニー 錠剤組成物
JP2003095981A (ja) * 2001-09-26 2003-04-03 Taisho Pharmaceut Co Ltd 医薬組成物

Similar Documents

Publication Publication Date Title
US5110605A (en) Calcium polycarbophil-alginate controlled release composition and method
AU774966B2 (en) Compositions for treatment of disorders of the oesophagus
JP2003527410A5 (ja)
CA2599585C (en) Compositions and methods of making sustained release liquid formulations
US5859060A (en) Timed release tablet comprising naproxen and pseudoepherine
ES2376199T3 (es) Un comprimido farmacéutico caracterizado por mostrar un incremento de volumen cuando entra en contacto con fluidos biológicos.
JPS62138428A (ja) 持続放出型医薬組成物
NZ709754A (en) Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
ES2963078T3 (es) Formulaciones de liberación inmediata disuasorias del abuso que comprenden polisacáridos no celulósicos
MXPA05008033A (es) Composiciones de milnacipran en forma de multiparticulas para administracion oral.
US20090317465A1 (en) Composition and method of preparation of release systems for constant (zero-order) release of active agents
BR112015021002B1 (pt) Forma de dosagem sólida farmacêutica compreendendo um ingrediente farmacêutico ativo
EP2358358A2 (en) Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
WO2006087961A1 (ja) 歯科用粘膜調整材
RU2010153904A (ru) Ниацин-содержащие композиции с модифицированным высвобождением
TW200502008A (en) Patches for mucosa of oral cavity containing fentanyl
JP2006008637A5 (ja)
CN1286629A (zh) 片剂组合物
GB2384986A (en) Solid compositions for the treatment of disorders of the upper gastrointestinal tract
WO2009041111A1 (ja) 経口投与剤
WO2003101422A3 (de) Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker
AU2010315414B2 (en) Fast dissolving/disintegrating coating compositions
JP2011516544A5 (ja)
Balamurugan et al. Development and in-vitro evaluation of mucoadhesive buccal tablets of domperidone
Yoonis et al. Tooth-colored dental restorative materials in primary dentition